Therefore, PD-1/PD-L1 down-regulation on CD4+ T cells or mDCs participates in the pathogenesis of AF and up-regulating the expression of PD-1/PD-L1 molecules may represent a new therapeutic option for AF. Here, PDCD1 is linked to atrial fibrillation.